News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
98,051 Results
Type
Article (5583)
Company Profile (10)
Press Release (92458)
Multimedia
Podcasts (10)
Webinars (5)
Section
Business (39444)
Career Advice (355)
Deals (7072)
Drug Delivery (17)
Drug Development (8630)
Employer Resources (29)
FDA (1406)
Job Trends (1773)
News (56048)
Policy (3956)
Tag
Academia (259)
Accelerated approval (1)
Adcomms (1)
Allergies (9)
Alliances (5334)
ALS (8)
Alzheimer's disease (147)
Antibody-drug conjugate (ADC) (22)
Approvals (1408)
Artificial intelligence (33)
Autoimmune disease (9)
Automation (5)
Bankruptcy (66)
Best Places to Work (1446)
BIOSECURE Act (2)
Biosimilars (14)
Biotechnology (11)
Bladder cancer (4)
Brain cancer (3)
Breast cancer (46)
Cancer (277)
Cardiovascular disease (10)
Career advice (311)
Career pathing (2)
CAR-T (22)
Cell therapy (72)
Cervical cancer (2)
Clinical research (6977)
Collaboration (133)
Compensation (26)
Complete response letters (3)
COVID-19 (328)
CRISPR (3)
C-suite (96)
Cystic fibrosis (20)
Data (255)
Denatured (2)
Depression (5)
Diabetes (53)
Diagnostics (780)
Digital health (4)
Diversity, equity & inclusion (10)
Drug discovery (24)
Drug pricing (12)
Drug shortages (5)
Duchenne muscular dystrophy (29)
Earnings (17075)
Editorial (13)
Employer branding (1)
Employer resources (27)
Events (10897)
Executive appointments (316)
FDA (1587)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Funding (150)
Gene editing (13)
Gene therapy (47)
GLP-1 (128)
Government (571)
Grass and pollen (1)
Guidances (29)
Healthcare (2956)
Huntington's disease (3)
IgA nephropathy (5)
Immunology and inflammation (20)
Indications (2)
Infectious disease (353)
Inflammatory bowel disease (34)
Influenza (10)
Intellectual property (26)
Interviews (43)
IPO (3039)
IRA (6)
Job creations (348)
Job search strategy (277)
Kidney cancer (2)
Labor market (8)
Layoffs (59)
Leadership (3)
Legal (1037)
Liver cancer (6)
Lung cancer (26)
Lymphoma (16)
Machine learning (1)
Management (7)
Manufacturing (69)
MASH (18)
Medical device (2075)
Medtech (2076)
Mergers & acquisitions (4200)
Metabolic disorders (114)
Multiple sclerosis (9)
NASH (3)
Neurodegenerative disease (17)
Neuropsychiatric disorders (4)
Neuroscience (222)
NextGen: Class of 2025 (956)
Non-profit (418)
Now hiring (3)
Obesity (51)
Opinion (49)
Ovarian cancer (17)
Pain (20)
Pancreatic cancer (6)
Parkinson's disease (19)
Partnered (1)
Patents (42)
Patient recruitment (16)
Peanut (4)
People (16548)
Pharmaceutical (10)
Pharmacy benefit managers (5)
Phase I (2242)
Phase II (3272)
Phase III (2432)
Pipeline (271)
Policy (26)
Postmarket research (159)
Preclinical (818)
Press Release (17)
Prostate cancer (16)
Psychedelics (7)
Radiopharmaceuticals (65)
Rare diseases (58)
Real estate (543)
Recruiting (15)
Regulatory (2683)
Reports (14)
Research institute (288)
Resumes & cover letters (44)
Rett syndrome (1)
RSV (4)
Schizophrenia (17)
Series A (40)
Series B (13)
Service/supplier (1)
Sickle cell disease (9)
Special edition (3)
Spinal muscular atrophy (16)
Sponsored (8)
Startups (540)
State (1)
Stomach cancer (1)
Supply chain (17)
Tariffs (4)
The Weekly (8)
Vaccines (101)
Venture capitalists (10)
Weight loss (35)
Women's health (7)
Worklife (2)
Date
Last 7 days (157)
Last 30 days (468)
Last 365 days (5512)
2025 (1970)
2024 (6061)
2023 (6557)
2022 (9089)
2021 (9318)
2020 (8360)
2019 (6547)
2018 (5123)
2017 (4782)
2016 (4474)
2015 (5165)
2014 (3872)
2013 (2932)
2012 (3197)
2011 (3315)
2010 (2976)
Location
Africa (110)
Alabama (6)
Alaska (2)
Arizona (32)
Arkansas (4)
Asia (6629)
Australia (957)
California (969)
Canada (447)
China (83)
Colorado (78)
Connecticut (48)
Delaware (24)
Europe (13806)
Florida (156)
Georgia (40)
Idaho (4)
Illinois (79)
India (2)
Indiana (76)
Japan (28)
Kansas (9)
Kentucky (2)
Louisiana (1)
Maine (5)
Maryland (180)
Massachusetts (627)
Michigan (20)
Minnesota (41)
Missouri (8)
Montana (13)
Nebraska (6)
Nevada (11)
New Hampshire (16)
New Jersey (433)
New Mexico (7)
New York (246)
North Carolina (182)
Northern California (446)
Ohio (41)
Oklahoma (3)
Oregon (2)
Pennsylvania (189)
Puerto Rico (7)
Rhode Island (5)
South America (173)
Southern California (357)
Tennessee (10)
Texas (162)
United States (3684)
Utah (32)
Virginia (14)
Washington D.C. (7)
Washington State (44)
West Virginia (1)
Wisconsin (4)
98,051 Results for "aspen pharmacare holdings".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dalen Meeter Joins Aspen Neuroscience as Chief Financial Officer
May 1, 2025
·
2 min read
Press Releases
ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints
April 25, 2025
·
8 min read
Press Releases
Aspen Neuroscience to Present at the International Society for Gene & Cell Therapy (ISCT) Annual Meeting
May 7, 2025
·
4 min read
Press Releases
Aspen Neuroscience Announces 6-Month ASPIRO Phase 1/2a Clinical Trial Results of Personalized Cell Therapy for Parkinson’s Disease
May 8, 2025
·
5 min read
Press Releases
Aspen Medical Products Acquires Advanced Orthopaedics
January 30, 2025
·
2 min read
Press Releases
Mytos Announces Manufacturing Collaboration with Aspen Neuroscience in Parkinson’s Disease
January 8, 2025
·
3 min read
Biotech Beach
Aspen Neuroscience to Present at International Society for Cell & Gene Therapy (ISCT) Annual Meeting
Aspen Neuroscience will present this week to a global audience of clinicians, regulators, researchers, technologists and industry partners at the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, May 29-June 1.
May 30, 2024
·
3 min read
Press Releases
ALX Oncology to Host Virtual Company Event Highlighting Updated Data from ASPEN-06 Phase 2 Trial Presented at 2025 ASCO GI
January 21, 2025
·
2 min read
Press Releases
Aspen Neuroscience Announces Completion of First and Second Cohorts in ASPIRO Phase 1/2a Trial for Parkinson’s Disease
January 13, 2025
·
3 min read
Drug Development
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer
ALX Oncology Holdings Inc., an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, presented data from its Phase 1 ASPEN-07 clinical trial in a poster presentation at the 2024 American Society of Cancer Oncology Annual Meeting being held in Chicago from May 31-June 4, 2024.
June 2, 2024
·
9 min read
1 of 9,806
Next
